Navigation Links
IsoTis - Integra Merger
Date:9/19/2007

t the merger. The IsoTis board of directors recommends that IsoTis stockholders approve the Agreement and Plan of Merger.

About IsoTis

IsoTis is an orthobiologics company that develops, manufactures and markets proprietary products for the treatment of musculoskeletal diseases and disorders. IsoTis' current orthobiologics products are bone graft substitutes that promote the regeneration of bone and are used to repair natural, trauma-related and surgically-created defects common in orthopedic procedures, including spinal fusions. IsoTis' current commercial business is highlighted by its Accell line of products, which the company believes represents the next generation in bone graft substitution.

On August 7, 2007 Integra and IsoTis announced that they have reached a definitive agreement to create a global orthobiologics leader. The combination would create a comprehensive orthobiologics portfolio, one of the largest sales organizations focused on orthobiologics in the US, and multiple cross-selling opportunities. The transaction is subject to approval of IsoTis' stockholders, as well as other closing conditions and approvals. Upon closing, IsoTis will become a wholly-owned subsidiary of Integra and Integra will be one of the largest companies in the world focused on advanced technology in orthobiologics.

Forward-Looking Statements

Certain statements in this press release are "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, IsoTis' proposed acquisition by Integra. Words such as "strategy," "expects," "plans," "anticipates," "believes," "may," "will," "might," "could," "would," "continues," "estimates," "intends," "pursues," "projects," "goals," "targets" or the negative or other variations thereof and other words of similar meaning are intended to identify such forward-looking statements. One can also identify them by the fact that they do not relate strictly to historical
'/>"/>

SOURCE IsoTis Inc
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Integration of the LEADseeker Multimodality Imaging System with automated plate loading and incubation using Overlord Instrument software
2. Improving an Integral Part of the Lab: Vacuum
3. TrafficCast integrates new information source
4. NSF grants bolster integrative graduate study at UW-Madison
5. Miszewski touts benefits of IT integration
6. Mediasite integrates with Blackboard
7. Johnson Controls buys stake in health-care tech integration firm
8. Education conference focusing on importance of integrating technology
9. Successful Wisconsin VC sets sights on data integration and mass storage
10. TeraMedica offers system integration tool for hospitals
11. Wisconsin crisis hotline gets Web-based integration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... N.J., Dec. 17 Osteotech, Inc. (Nasdaq: ... field of biologic products for regenerative healing, announced ... to the United States Food and Drug Administration ... of its Duratech(TM) BioRegeneration Matrix to repair or ... the brain) in various cranial surgical procedures. ...
(Date:12/17/2009)... Institute,s Top 10 Health Industry Issues in 2010, puts healthcare cost ... for the year ahead. , ... New York, ... Top 10 Health Industry Issues in 2010, puts ... the overarching theme for the year ahead. , , , , ...
(Date:12/17/2009)... the Rx Club, the Daveys, the GLOBALS, ,and PM360 Pharma ... ... December 17, 2009 -- Chicago-based full-service healthcare communications agency Goble ... marketing awards programs honoring exceptional creative and interactive work. , ... G&A with 9 Awards of Excellence for the following creative ...
(Date:12/16/2009)... historians, journalists and politicians, and has been recounted everywhere ... Congress: British forces used chemical weapons on Iraqis just ... has never been fully squared with the historical record, ... According to Douglas,s research, forthcoming in the December issue ... such incident ever occurred. , Allegations of chemical ...
Breaking Biology Technology:Osteotech Submits 510(k) Application to FDA for Clearance of its Duratech(TM) BioRegeneration Matrix 2Osteotech Submits 510(k) Application to FDA for Clearance of its Duratech(TM) BioRegeneration Matrix 3Squeezing Costs out of Healthcare Tops PricewaterhouseCoopers' List of Health Industry Issues in 2010, 2Squeezing Costs out of Healthcare Tops PricewaterhouseCoopers' List of Health Industry Issues in 2010, 3Squeezing Costs out of Healthcare Tops PricewaterhouseCoopers' List of Health Industry Issues in 2010, 4Squeezing Costs out of Healthcare Tops PricewaterhouseCoopers' List of Health Industry Issues in 2010, 5Goble & Associates Creative Work Awarded at Advertising Industry Competitions 2Goble & Associates Creative Work Awarded at Advertising Industry Competitions 3Goble & Associates Creative Work Awarded at Advertising Industry Competitions 4Despite claims, UK did not gas Iraqis in the 1920s, new research finds 2Despite claims, UK did not gas Iraqis in the 1920s, new research finds 3Despite claims, UK did not gas Iraqis in the 1920s, new research finds 4
... will release its third quarter 2007 financial results on ... will be available,on the PPD Web site at ... October 24, at 9 a.m. ET, PPD will conduct ... results and the,overall business environment. A Q&A session will ...
... LAVAL, QC, Sept. 28 /PRNewswire-FirstCall/ - Neptune Technologies ... report its,financial results for the fiscal year ended ... improved its productivity and operational,profitability while continuing its ... Asian markets, resulting in,sustainable sales growth. Financial ...
... Oncolytics Biotech Inc.,("Oncolytics") (TSX:ONC, NASDAQ:ONCY) today announced ... a U.K. Phase Ia/Ib combination,REOLYSIN(R) and radiation ... cancers is scheduled to be presented at ... October 2, 2007 in Birmingham, U.K.,The presentation, ...
Other Biology Technology:PPD Announces Third Quarter 2007 Earnings Release, Webcast and Conference Call 2Neptune Reports Year End Financial Results - Neptune Records 18% Sales Increase and 43% EBITDA Increase in Year End Results 2Neptune Reports Year End Financial Results - Neptune Records 18% Sales Increase and 43% EBITDA Increase in Year End Results 3Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial 2Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial 3Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial 4
(Date:12/16/2009)... DigitalPersona, Inc., a leader in ... an agreement with IBM to deploy a ... technology on IBM SurePOS 500 retail systems. ... applications to more easily and quickly identify ... linked to the individuals who perform them. ...
(Date:12/16/2009)... IgeaCare Solutions Inc. is pleased to ... healthcare communications company previously operating as IgeaCare Systems ... move forward under new leadership and funding. ,, ... to the position of Chief Executive Officer. Under ... providing a superior servicing and support model; fast ...
(Date:12/16/2009)... Va., Dec. 9 CSC (NYSE: ... the American Association for Laboratory Accreditation awarded ... (ISO/IEC) 17025:2005 accreditation to the company,s Test ... Identity Labs located in Fairmont, W.Va. The ... laboratory in the world to achieve this ...
Breaking Biology News(10 mins):DigitalPersona Fingerprint Sensor Technology Ships on IBM SurePOS 500 Retail Systems 2IgeaCare Solutions Inc. Emerges Under New Leadership and Funding 2CSC's Identity Management and Biometric Test Lab Achieves ISO/IEC 17025 Accreditation 2Weber Shandwick Chosen By National Marrow Donor Program 28R 29 To Head Awareness Campaign 47925 1Weber Shandwick Chosen By National Marrow Donor Program 28R 29 To Head Awareness Campaign 47925 2Weber Shandwick Chosen By National Marrow Donor Program 28R 29 To Head Awareness Campaign 47925 3MD On Line Inc Acquires Medical Claim Corp 47920 1MD On Line Inc Acquires Medical Claim Corp 47920 2Jefferson researchers identify critical marker of response to gemcitabine in pancreatic cancer 47918 1Jefferson researchers identify critical marker of response to gemcitabine in pancreatic cancer 47918 2
... A new study has found that large segments of ... phytoplankton growth and the absence of the mineral stresses ... pigments that make ocean productivity appear more robust than ... of satellite chlorophyll data may be inaccurate, the researchers ...
... relatively benign compound contained in a widely used group ... of existing pesticides in the environment, according to a ... California, Berkeley. , While the increase in toxicity was ... were unexpected, the researchers said. , The study's results, ...
... researchers has created technology to regrow teeth--the first time ... , Using low-intensity pulsed ultrasound (LIPUS), Dr. Tarak El-Bialy ... Jie Chen and Dr. Ying Tsui from the Faculty ... a non-invasive and novel way to stimulate jaw growth ...
Other Biology News:Iron critical to ocean productivity, carbon uptake 2Iron critical to ocean productivity, carbon uptake 3Mosquito spray increases toxicity of pyrethroids in creek, study finds 2Mosquito spray increases toxicity of pyrethroids in creek, study finds 3Mosquito spray increases toxicity of pyrethroids in creek, study finds 4Ultrasound may help regrow teeth 2